{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T21:01:12Z","timestamp":1780174872490,"version":"3.54.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jchromb.2026.125113","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:42:15Z","timestamp":1778593335000},"page":"125113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and fit-for-purpose validation of human scalp hair analysis using UHPLC-MS\/MS for determining exposure to CFTR modulators"],"prefix":"10.1016","volume":"1280","author":[{"given":"A. Mireille A.","family":"Wessels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina M.E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.L.A.","family":"van den Bemt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job F.M.","family":"van Boven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jchromb.2026.125113_bb0005","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jchromb.2026.125113_bb0010","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.lpm.2017.04.012","article-title":"The changing epidemiology and demography of cystic fibrosis","author":"Stephenson","year":"2017","journal-title":"Presse Med. Elsevier Masson s.r.l."},{"issue":"5","key":"10.1016\/j.jchromb.2026.125113_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2015.05.009","article-title":"Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor","volume":"14","author":"Siracusa","year":"2015","journal-title":"J. Cyst. Fibros."},{"issue":"173","key":"10.1016\/j.jchromb.2026.125113_bb0020","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0060-2024","article-title":"Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review","volume":"33","author":"Hansen","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jchromb.2026.125113_bb0025","series-title":"Quantitative Method for the Analysis of Ivacaftor, Hydroxymethyl Ivacaftor, Ivacaftor Carboxylate, Lumacaftor, and Tezacaftor in Plasma and Sputum Using Liquid Chromatography With Tandem Mass Spectrometry and Its Clinical Applicability [Internet]","author":"SEM","year":"2021"},{"key":"10.1016\/j.jchromb.2026.125113_bb0030","article-title":"Correlation between trough concentration and AUC for elexacaftor, tezacaftor and ivacaftor","author":"SEM","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jchromb.2026.125113_bb0035","doi-asserted-by":"crossref","DOI":"10.1007\/s41030-026-00351-4","article-title":"Long-term adherence to Elexacaftor\/Tezacaftor\/Ivacaftor in people with cystic fibrosis","author":"Hansen","year":"2026","journal-title":"Pulm Ther."},{"issue":"7","key":"10.1016\/j.jchromb.2026.125113_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2022.04.1509","article-title":"PCR166 adherence to cystic fibrosis transmembrane regulator modulator therapies, hospitalizations, and medical costs in patients with cystic fibrosis using Marketscan commercial claims and encounters database","volume":"25","author":"Zhou","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.jchromb.2026.125113_bb0045","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s40265-021-01618-7","article-title":"Clinical value of emerging bioanalytical methods for drug measurements: a scoping review of their applicability for medication adherence and therapeutic drug monitoring","author":"Zijp","year":"2021","journal-title":"Drugs. Adis"},{"issue":"22","key":"10.1016\/j.jchromb.2026.125113_bb0050","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.jchromb.2011.05.034","article-title":"Screening and quantitation of multiclass drugs of abuse and pharmaceuticals in hair by fast liquid chromatography electrospray time-of-flight mass spectrometry","volume":"879","author":"Dom\u00ednguez-Romero","year":"2011","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"1\u20133","key":"10.1016\/j.jchromb.2026.125113_bb0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.forsciint.2009.12.027","article-title":"Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS","volume":"196","author":"Nielsen","year":"2010","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2026.125113_bb0060","first-page":"1258","article-title":"Quantification of ivacaftor, tezacaftor, elexacaftor, and lumacaftor and their active metabolites in plasma using UHPLC-MS\/MS: doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment","author":"Wessels","year":"2025","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"1\u20133","key":"10.1016\/j.jchromb.2026.125113_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.forsciint.2011.10.024","article-title":"Society of hair testing guidelines for drug testing in hair","volume":"218","author":"Cooper","year":"2012","journal-title":"Forensic Sci. Int."},{"issue":"11","key":"10.1016\/j.jchromb.2026.125113_bb0070","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1007\/s00204-022-03343-w","article-title":"One-step extraction and determination of 513 psychoactive substances, drugs, and their metabolites from hair by LC\u2013MS\/MS","volume":"96","author":"Musia\u0142","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jchromb.2026.125113_bb0075","first-page":"1624","article-title":"Determination of steroid profile in hair by liquid chromatography tandem mass spectrometry","author":"Gomez-Gomez","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125113_bb0080","article-title":"Development of an UPLC\u2013MS\/MS method for the analysis of 16 synthetic opioids in segmented hair, and evaluation of the polydrug history in fentanyl analogue users","volume":"307","author":"del M","year":"2020","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2026.125113_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116054","article-title":"Validation and application of a method for the quantification of 137 drugs of abuse and new psychoactive substances in hair","author":"Barone","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125113_bb0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.forsciint.2017.11.027","article-title":"Systematic assessment of different solvents for the extraction of drugs of abuse and pharmaceuticals from an authentic hair pool","volume":"282","author":"Madry","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2026.125113_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2025.127769","article-title":"Portable solvent-assisted thermal desorption ionization mass spectrometry for highly sensitive detection of illicit drugs in hair","volume":"289","author":"Wu","year":"2025","journal-title":"Talanta"},{"issue":"2","key":"10.1016\/j.jchromb.2026.125113_bb0100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/10826084.2024.2423366","article-title":"Hair cortisol concentrations in the prediction of early substance use engagement in youth","volume":"60","author":"Georgiades","year":"2025","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.jchromb.2026.125113_bb0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11419-022-00619-9","article-title":"Micro-segmental hair analysis: detailed procedures and applications in forensic toxicology","author":"Kuwayama","year":"2022","journal-title":"Forensic Toxicol. Springer"},{"key":"10.1016\/j.jchromb.2026.125113_bb0115","series-title":"Bioanalytical Method Validation Guidance for Industry Biopharmaceutics Bioanalytical Method Validation Guidance for Industry Biopharmaceutics Contains Nonbinding Recommendations [Internet]","author":"Fda, Cder","year":"2018"},{"key":"10.1016\/j.jchromb.2026.125113_bb0120","series-title":"SoHT consensus on general recommendations for hair testing","year":"2022"},{"issue":"13","key":"10.1016\/j.jchromb.2026.125113_bb0125","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125113_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jchromb.2016.10.026","article-title":"Development of HPLC and LC\u2013MS\/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO","volume":"1038","author":"Schneider","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2026.125113_bb0135","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1021\/acs.chemrestox.9b00301","article-title":"Extraction procedures for hair forensic toxicological analysis: a mini-review","author":"Ferreira","year":"2019","journal-title":"Chem. Res. Toxicol. American Chemical Society"},{"key":"10.1016\/j.jchromb.2026.125113_bb0140","doi-asserted-by":"crossref","DOI":"10.1007\/s00228-025-03903-w","article-title":"Hair analysis for monitoring adherence to inhaled respiratory medications: possibilities and limitations","author":"Cuperus","year":"2025","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125113_bb0145","first-page":"315","article-title":"Development and full validation of a multiresidue method for the analysis of a wide range of pesticides in processed fruit by UHPLC-MS\/MS","author":"Valera-Tarifa","year":"2020","journal-title":"Food Chem."},{"key":"10.1016\/j.jchromb.2026.125113_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1693712","article-title":"Stability of formoterol concentration in scalp hair of patients using maintenance formoterol therapy for asthma or COPD (INCTFISH)","volume":"16","author":"Sportel","year":"2025","journal-title":"Front. Pharmacol."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226002023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226002023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T20:23:08Z","timestamp":1780172588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"alternative-id":["S1570023226002023"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125113","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and fit-for-purpose validation of human scalp hair analysis using UHPLC-MS\/MS for determining exposure to CFTR modulators","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125113"}}